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Summary 
Because of the worldwide aging of populations, Alzheimer’s 
disease and other dementias constitute a devastating experience 
for patients and families as well as a major social and economic 
burden for both healthcare systems and society. Multiple poten-
tially modifiable cardiovascular and lifestyle risk factors have 
been associated with this disease. Thus, modifying these risk 
factors and identifying protective factors represent important 
strategies to prevent and delay disease onset and to decrease 
the social burden. Based on the cognitive reserve hypothesis, 
evidence from epidemiological studies shows that low education 
and cognitive inactivity constitute major risk factors for demen-
tia. This indicates that a cognitively active lifestyle may protect 
against cognitive decline or delay the onset of dementia. We 
describe a newly developed preventive programme, based on 
this evidence, to stimulate and increase cognitive activity in older 
adults at risk for cognitive decline. This programme, called 
“BrainCoach”, includes the technique of “motivational interview-
ing” to foster behaviour change. If the planned feasibility study is 
successful, we propose to add BrainCoach as a module to the 
already existing “Health Coaching” programme, a Swiss preven-
tive programme to address multiple risk factors in primary care. 
Key words: Alzheimer’s disease; cognitive impairment; dementia; 
prevention; cognitive reserve; BrainCoach; protective factors; 
motivational interviewing 
Introduction 
The increase of life expectancy over the last century is paralleled by 
an elevated number of individuals with dementia, placing an enor-
mous social and economic burden on society and healthcare systems, 
in addition to the devastating consequences for patients and their 
families. According to the World Alzheimer Report 2015, an estimat-
ed 47 million people worldwide suffer from dementia [1]. Based on 
current simulation models, the number of cases is expected to at least 
double every 20 years, reaching almost 132 million cases by 2050. 
However, recent reports suggest that the age-specific incidence of 
dementia might be decreasing in persons with at least a high school 
diploma, possibly owing to an improvement in cardiovascular health 
[2, 3]. Nevertheless, and irrespective of how fast the growth in the 
number of people with dementia will be, the economic impact associ-
ated with dementia is huge and increasing. Worldwide, the current 
total costs have increased by 35% in the last five years and were 
estimated to be USD 818 billion in 2015, representing 1% of the 
global gross domestic product [1]. These costs include direct medical 
care costs (dementia treatment in primary and secondary care), direct 
social care costs (community care professionals and residential 
homes) and informal care costs (unpaid care by family and others) [1].  
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In Switzerland, based on current simulation models, the number of 
people with dementia was estimated to be 119 000 in 2015, and this 
number is predicted to increase up to 300 000 by 2050 [4]. Annually, 
there are 27 000 new cases of dementia. The annual costs amount to 
approximately CHF 7 billion, imposing an enormous economic bur-
den on Swiss society [5]. 
Although several causes of dementia exist, we will focus this review 
on its most common cause, Alzheimer's disease. Alzheimer’s disease 
is clinically characterised by an insidious onset and a progressive 
deterioration of cognitive function, which typically starts with a 
decline in memory functions [6, 7]. Pathologically, Alzheimer’s 
disease is characterised by increased levels of extracellular amyloid-β, 
intracellular hyperphosphorylated tau proteins, and neuronal and 
synaptic loss in the neocortex [8, 9]. Despite decades of research, the 
pathological mechanisms underlying these disease-related changes 
still remain largely unclear. However, there is a broad consensus that 
Alzheimer’s disease has a complex multifactorial aetiology and is 
modulated by various risk factors [10–13]. While advancing age [14] 
and specific genetic predispositions (e.g., APOE-ε4 [15, 16]) are well-
recognised unmodifiable main risk factors for sporadic Alzheimer’s 
disease, additional potentially modifiable factors have been linked to 
the development of the disease. Specifically, observational studies 
indicate that cardiovascular risk factors (e.g., hypertension, diabetes, 
cerebrovascular disease, obesity, metabolic syndrome), lifestyle 
factors (e.g., unhealthy diet, smoking, high alcohol intake, low cogni-
tive, social and physical activity, chronic stress) and psychosocial 
factors (e.g., lack of a rich social network, depressive symptoms) have 
an impact on the risk for Alzheimer’s disease and other forms of 
dementia (for an overview see [12, 17–19]. Additionally, individual 
risk factors are often closely linked and thus co-occur during a per-
son’s lifetime: A recent estimate by Norton et al. [11] implies that, 
taking into account the interdependency of these factors, about one 
third of Alzheimer’s disease cases worldwide may be attributable to 
seven potentially modifiable risk factors: diabetes, midlife hyperten-
sion, midlife obesity, depression, physical inactivity, smoking, and 
low educational attainment (fig. 1; see also [10]). 
 
 
 
Figure 2: Hypothesised model of 
neurocognitive disorders [26] 
across lifespan without (black 
line) and with (orange dashed 
line) successful modification of 
risk and protective factors and 
the consequence on dementia 
incidence rates: natural course 
(green line) vs result of optimally 
timed preventive strategies 
through primary, secondary and 
tertiary prevention (blue dashed 
line). Figure adapted from [24] 
and [25], reproduced with 
permission. 
 
Figure 1: Prevalence and estimates for 
population-attributable risks for Alzheimer’s 
disease in 2010. Data source: Norton et al. 
[11]. PAR = population-attributable risk, the 
proportion of Alzheimer’s disease cases in the 
population that can be attributed to individual 
risk factors calculated by using the population 
prevalence and the relative risk of the risk 
factor. Combined = calculated prevalence and 
PAR for the seven individual risk factors 
combined, assuming independence of the risk 
factors. Adjusted combined = calculated 
prevalence and PAR for all seven risk factors 
combined with adjustment for non-
independence of the risk factors. 
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Whereas current pharmacological and nonpharmacological treatments 
may decelerate disease progression, no curative or disease-modifying 
intervention exists to prevent the pathogenesis of dementia [20, 21]. 
Thus, there is a pressing need to identify preventive measures and 
strategies aiming to maintain brain health and delay cognitive decline. 
Importantly, because neurodegenerative disorders such as Alzheimer’s 
disease have a long “silent” phase with no or only very subtle symp-
toms [22], such preventive programmes should optimally be imple-
mented at the earliest possible time when cognitive impairments are 
not yet manifest [23–25]. Figure 2 illustrates that preventive strategies 
require a lifespan perspective. Thus, children and adolescents need to 
be targeted with regard to education and, starting at midlife, optimal 
management of potential risk factors is essential [26]. 
Different modifiable factors to preserve cognitive health have been 
described. A healthy diet (e.g., Mediterranean) rich in antioxidants, 
vitamins (e.g., vitamins B12, E and D) and polyunsaturated fatty acids 
(e.g., omega-3 [27]) may lower the risk of cognitive decline and 
dementia by reducing, for example, the risk for cardiovascular diseas-
es [28, 29]. However, although findings from different studies suggest 
that specific dietary patterns or nutritional components may represent 
promising interventions in delaying cognitive decline, evidence in this 
regard is still weak and further investigation on this topic is needed 
[30, 31]. Additionally, physical activity is also known to exert benefi-
cial effects on brain health. Promising results from different observa-
tional and intervention studies, as well as systematic reviews, examin-
ing the association between physical activity and the risk of cognitive 
impairment and dementia, yielded promising results, with moderate to 
strong effects of physical activity on brain health. These results indi-
cate that individuals with a physically active lifestyle exhibit less 
cognitive decline [32–35], reduced brain atrophy [36] and increased 
hippocampal volume [37] compared with people with a sedentary 
lifestyle. A third important protective factor for the maintenance of 
brain health is cognitive activity. This aspect will be reviewed in more 
detail below and a new module within the Swiss Health Coaching 
programme [38], the “BrainCoach”, which focuses on cognitive 
activity as a preventive measure of cognitive decline, is introduced. 
Cognitive activity as a modifiable protective factor 
for cognitive decline 
As shown in figure 1, low educational attainment [11] or cognitive 
inactivity [10] constitutes the largest single risk factor for Alzheimer’s 
disease. Certainly, high educational attainment will not prevent patho-
logical brain changes; however, a number of studies indicate that 
higher educational attainment is related with higher levels of cognitive 
performance and seems to buffer negative effects and mitigate clinical 
symptoms in everyday life [2, 39–43]. The rationale behind this 
observation is the hypothesis that higher educational attainment results 
in an increased cognitive reserve [42, 44]. This so-called cognitive 
reserve hypothesis implies that individuals with higher levels of brain 
activity (e.g., through individual or synergistic contributions of high 
educational/occupational attainment and maintained cognitive activity 
up until old age) may better cope with brain pathology and are able to 
compensate for brain damage much longer because of increased 
synaptic densities and a more complex and efficient structure of neural 
networks [23, 42]. Thus, people with the same extent of pathological 
brain changes may exhibit different clinical manifestations of the 
disease depending on their level of cognitive reserve [39] (fig. 3, 
[44]). 
Importantly, a person with a high cognitive reserve will have a steeper 
decline once symptoms are manifest, as a result of higher pathological 
accumulations in the brain, until cognitive dysfunctions are clinically 
perceivable [44]. 
These findings are supported by several studies reporting reduced 
incidence rates of cognitive impairment and dementia in older adults 
with a high educational attainment [2, 39–43]. Additionally, an analy-
sis from Barnes and Yaffe [10] indicates that the relative risk of 
developing dementia (the ratio of the probability of developing de-
mentia in an at-risk group compared with a no-risk group) in people 
with a low education (primary education only) is 59% higher than in 
people with a higher education. 
However, older adults experiencing a cognitive decline have obvious-
ly already completed their formal and occupational education. The 
cognitive reserve, however, is not influenced by education alone. 
Retrospective studies indicate that significant associations exist be-
tween cognitively activating leisure activities, engagement in social 
activities and the level of cognitive performance, and the risk of 
dementia [45–47]. Moreover, studies show that performing cognitive-
ly stimulating leisure activities later in life may somewhat compensate 
for a low educational attainment [48, 49]. Thus, cognitive reserve is 
not a static condition, but can be influenced and enhanced at any point 
in someone’s lifetime. 
The great diversity of cognitive tasks and the variability in the dura-
tions of exposure to cognitive tasks in different studies investigating 
the association between cognitive activity and risk of dementia meant 
that some studies also had inconclusive findings (see for example 
[50]). Nevertheless, there is substantial evidence that participating in 
cognitive activities conveys beneficial effects for the maintenance of 
brain health and may delay cognitive decline [46, 47]. Various exper-
imental studies on rodents [50, 51] and imaging studies on humans 
[52–54] suggest that a mentally stimulating environment promotes 
neurotrophic changes in the hippocampal formation, neurogenesis and 
synaptic density. For example, a study by Lazarov et al. [55] with 
transgenic mice corroborated the idea that a cognitively stimulating 
environment (housing in a cave with running wheels, colourful tunnels 
and assorted toys) results in an increased clearance of amyloid-β 
deposits compared with mice held in standard housing. Additionally, 
an imaging study by Valenzuela et al. [52] with healthy older human 
adults showed that participants with high levels of mental activity (in 
the domains of education, occupation, creative arts, reading, writing, 
socialising and day-to-day habits) across their lifespan (young adult-
 
Figure 3: Illustration of the association be-
tween the emergence of dementia-associated 
neuropathology, its clinical expression and 
cognitive reserve. Figure adapted from [45]; 
reproduced with permission. Educational 
attainment and occupational challenges can 
usually no longer be changed in individuals 
aged 50 years and older. However, cognitive 
leisure activities may increase their cognitive 
reserve and thus lead to a delay in the emer-
gence of cognitive decline. 
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hood, middle age and late life) exhibited a reduced rate of hippocam-
pal atrophy compared with those with low levels. 
A Cochrane review [56] examining the effect of cognitive training 
(the structured practice of tasks targeting specific domains of cogni-
tive functioning) with 36 included studies involving healthy older 
participants or people with mild cognitive impairment provided evi-
dence for an improvement in immediate and delayed verbal recall 
compared with participants without training. However, this positive 
effect did not exceed the improvements in active control groups 
receiving “only” nonspecific cognitive stimulation, such as reading, 
playing board games or dancing, which may significantly reduce the 
risk for cognitive decline or dementia (see also for example [47, 48, 
57]). Moreover, various studies revealed that musical activities (play-
ing an instrument or singing) enhances performance in different 
cognitive domains (attention, executive functions) by promoting 
neural plasticity and increasing grey matter volume in frontal, motor, 
parietal and temporal (e.g., hippocampal) areas [53, 54, 57–59]. 
In summary, there is hopeful evidence that nonpharmacological 
interventions in stages with no or very little cognitive impairment may 
be effective in delaying (further) cognitive decline. Optimally, such a 
programme should address all possible preventive aspects: dietary 
habits, physical activity, intake of toxic substances (smoking behav-
iour and alcohol consumption) and cognitive activity. 
Prevention studies with a multidimensional  
approach 
Although observational studies confirm the association between the 
modifiable risk factors mentioned and Alzheimer’s disease, results 
from intervention studies investigating the effect of these factors in 
delaying the onset of cognitive decline or Alzheimer’s disease are 
mixed. These inconsistent findings may have resulted from various 
methodological problems including small samples, short intervention 
periods with short follow-up, inappropriate timing (too late to obtain a 
significant intervention effect [24]) or a mono-interventional approach 
investigating only one risk factor [19]. However, as the underlying 
pathology of Alzheimer’s disease is multifactorial, measures address-
ing multiple target areas aiming to modify vascular and lifestyle 
factors simultaneously seem more appropriate.  
To date, there are three large ongoing European intervention studies 
targeting simultaneously multiple risk factors: the Finnish Geriatric 
Intervention Study to Prevent Cognitive Impairment and Disability 
(FINGER [60, 61], the Prevention of Dementia by Intensive Vascular 
Care (PreDIVA [62, 63], study and the study Multidomain Alzheimer 
Preventive Trial (MAPT [64–66]). Until now, only preliminary results 
from these studies have been published. In 2011, the European De-
mentia Prevention Initiative (EDPI; http://www.edpi.org/) was 
launched to combine the valuable information collected in the three 
ongoing European trials mentioned above. The aim of this initiative is 
to improve and promote the collaboration between researchers in-
volved in the field of dementia prevention to combine experience and 
datasets, and better to define target populations, intervention strategies 
and methodological challenges in large dementia prevention trials 
[24]. Based on the studies mentioned above, an innovative and inter-
active Internet intervention platform for the treatment of cardiovascu-
lar disease in older people, called Healthy Ageing Through Internet 
Counselling in the Elderly (HATICE), was initiated as an additional 
project by the members of the EDPI (http://www.hatice.eu/). An 
additional initiative from Switzerland named “EviPrev” is based on 
current scientific data and focuses on evidence-based prevention and 
early detection of potentially chronic diseases (short interventions on 
physical activity, nutrition, smoking, alcohol consumption and screen-
ing for high blood pressure, dyslipidaemia, diabetes, breast cancer, 
colon cancer, and others) in the primary healthcare setting. Although 
this project is not considered to be a prevention study with a multidi-
mensional approach, it has an important impact on cognitive health by 
systematically recording cardiovascular risk factors. A systematic 
assessment of these risk factors, which significantly affect cognitive 
health, is crucial for effective treatments and successful lifestyle 
interventions [67, 68]. 
Health Coaching: a multidimensional counselling 
programme to promote health behaviour in the pri-
mary care setting 
Based on the findings summarised so far, an additional multidimen-
sional and structured health programme of counselling in primary care 
practice called “Health Coaching” was developed by the Swiss Col-
lege of Primary Care Medicine (http://www.gesundheitscoaching-
khm.ch/ [38]). Designed for general practitioners (GPs), the primary 
aim of this programme is to promote health behaviour in the Swiss 
population and prevent chronic diseases (e.g., stroke, coronary heart 
disease, cardiovascular disease) by targeting the most important 
contributors to disease burden including smoking, alcohol consump-
tion, body weight, dietary habits, level of physical activity, and coping 
strategies with stress [38, 69]. The aim is to give GPs the tools to 
motivate their patients and support them during the implementation of 
a healthier lifestyle. Patients are involved in the decision process and 
share the responsibility for their health with the practitioner. Thus, an 
important aspect of Health Coaching is that patient and health profes-
sional meet on equal terms and jointly plan a step-by-step health 
programme based on the patient’s individual preferences and abilities 
[38]. The programme also emphasises the high importance of the GPs’ 
communication skills and offers specific training programmes in 
“motivational interviewing” (see below) within this programme [70]. 
In a nonrandomised study, the programme showed high acceptability, 
feasibility and improvements in health-related behaviour [38]. Alt-
hough Health Coaching as a nonpharmacological programme is quite 
comprehensive and probably sufficient for individuals who are still in 
the workforce, it could benefit from an additional module focusing on 
cognitive activity for patients who are beyond retirement or who 
exhibit subtle cognitive problems. 
BrainCoach: a programme to promote  
cognitive activity 
Cognitive activity 
Based on scientific data reviewed above we have developed a cogni-
tive activity module to complement the Health Coaching programme. 
This programme, named “BrainCoach”, was specifically created for 
older adults at risk for cognitive impairment who might be, for exam-
ple, in the so-called “silent phase” of Alzheimer’s disease [22]. It is 
meant to be implemented in the primary care setting and to be con-
ducted by the GPs and other healthcare professionals (e.g., psycholo-
gists). The primary purpose of this module is – in accordance with the 
theory of cognitive reserve described above and the rule of “Use it or 
lose it!” – to support older adults and promote their motivation to 
maintain and increase brain health by increasing their cognitive activi-
ty. The programme addresses especially older adults feeling cognitive-
ly “bored” in everyday life, individuals shortly before retirement or 
individuals with subtle cognitive alterations. The promotion of the 
activity will be achieved by use of a specific folder (A4-format) 
including information about cognitive activity and its effects on brain 
health, communication skills (motivational interviewing) and a struc-
tured questionnaire as a guideline (working sheet) to evaluating the 
patients’ current cognitive activity and increase their motivation to 
find and implement a cognitive activity in their daily life. The Brain-
Coach intentionally does not include specific cognitive exercises, but 
highlights the importance of eliciting the patients’ motivation to find a 
cognitive activity that they like to perform regularly (e.g., something 
they performed earlier in their life). In case the patients cannot think 
of any cognitive activity they would like to engage in, the “Brain-
Coach” module offers a range of different cognitive activities – a 
“cognitive buffet” (different activities depicted in colour photographs) 
– from which the patients may choose the ones they loved to perform. 
Possible activities include those that can be performed individually, 
such as doing artwork, solving crossword puzzles, singing, playing a 
musical instrument, or reading books/newspapers. Activities carried 
out in groups have an additional stimulating component, especially 
due to the need of social interactions. Examples of these kinds of 
activities include language courses, dancing classes, singing in a choir, 
reading circles, attending university for seniors, playing board games, 
or attending cultural events with friends (e.g., theatre, cinema, and 
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concerts). This list included in the BrainCoach programme cannot be 
exhaustive, since a variety of additional activities may positively 
affect brain health. The patients are free to choose something from this 
list or to engage in another cognitively stimulating activity. The 
BrainCoach programme is cost-free; however, costs associated with 
the chosen activities have to be covered by the patients. 
Motivational interviewing 
Mathematically speaking, it would make the most sense to especially 
inspire patients with a low cognitive reserve to (newly) engage in 
cognitive activities, since these individuals have the largest room for 
improvement (see fig. 3). Thus, the technique used to motivate pa-
tients will be critical. The main technique used in the module Brain-
Coach, analogous to Health Coaching, is motivational interviewing 
[71], a well-known client-centred and collaborative counselling tech-
nique that has frequently and successfully been applied in general 
healthcare settings and health promotion [72]. Briefly, eliciting peo-
ple’s intrinsic motivation appears to be a key factor to achieve long-
lasting behavioural change [73–75]. For example, in BrainCoach a 
cognitive activity is chosen from the cognitive buffet because of the 
patient’s personal interest in the activity. Its motivation is more likely 
to be intrinsic, because the patient probably chose this activity for 
being enjoyable, pleasurable, or giving satisfaction. Importantly, 
because patient and health practitioner work together at ground level 
to identify a suitable cognitive activity, engagement in this activity is 
not extrinsically motivated: the patient does not engage in this activity 
to receive a reward, or because of feeling obliged. Importantly, moti-
vational interviewing is based on the principles of a good and equal 
partnership/collaboration between the GP / healthcare professional 
and the client, the evocation of a client’s personal values and intrinsic 
motivation, and the client’s autonomy to decide what to do (or not). 
Motivational interviewing can be used in a brief intervention format, 
making it suitable for the primary care setting. As motivating and 
supporting patients to make health-related behavioural changes repre-
sent a challenge for GPs, profound communication skills are crucial 
for successful counselling. Within BrainCoach, a training programme 
for GPs in motivational interviewing will be developed.  
The BrainCoach module, including the folder, the “cognitive buffet” 
and a structured questionnaire (worksheet) based on the communica-
tion skills included in motivational interviewing is currently being 
tested in a pilot study (feasibility, acceptance of the documents and the 
concept), which will be finalised and evaluated by March 2017. Its 
acceptance and feasibility by the patients and the impact on cognition 
and dementia incidence will be evaluated more extensively after-
wards, in a comprehensive study with an adequate and robust study 
design. 
Conclusions 
Because of demographic change, dementia represents a major 
healthcare issue for our society. Although the underlying pathogenesis 
of Alzheimer’s disease is not fully understood, a number of observa-
tional studies provide strong evidence for an adverse effect of multiple 
cardiovascular and lifestyle risk factors [12]. In this regard, prevention 
strategies are needed to manage and lower the increase of dementia 
cases influenced by these risk factors. Delaying cognitive decline and 
dementia would have a huge impact on its incidence and prevalence. 
Specifically, a 10–20% reduction of the seven main risk factors for 
Alzheimer’s disease (diabetes, midlife hypertension, midlife obesity, 
physical inactivity, depression, smoking, low educational attainment) 
would decrease Alzheimer’s disease prevalence by 8–15% by 2050 
[11]. Additionally, estimates from a projection model imply that 
interventions with the potential to delay disease onset or progression 
by only 1 year would reduce the number of Alzheimer’s disease 
patients by about 11% (9 million cases [75]). Understanding the 
contribution and the impact of different lifestyle factors on disease 
development will have an important influence on future disease man-
agement and treatment since many of these risk factors are modifiable. 
Thus, prevention programmes and strategies targeting the modifica-
tion of these factors seem a viable and reasonable approach to mitigate 
and delay cognitive decline and dementia [13]. Various factors includ-
ing a healthy diet, smoking cessation, a physically active lifestyle and 
cognitive activity have been proposed to exert protective effects on 
both physical and mental health. The Health Coaching programme 
developed by the Swiss College of Primary Care Medicine represents 
a comprehensive concept simultaneously targeting multiple risk 
factors. However, scientific evidence supports the importance of 
cognitive activity to maintain or increase cognitive reserve. Therefore, 
the module BrainCoach may represent a promising tool. Motivational 
interviewing as an empathetic, nonconfrontational and collaborative 
communication method has been shown to be effective for long-term 
behavioural change in several areas. The Health Coaching programme 
together with the BrainCoach, using the motivation interviewing 
counselling technique, could be a valuable, effective and low-cost 
approach to maintain both, physical and mental health. These pro-
grammes have important and promising implications for preventive 
intervention against cognitive decline and dementia. 
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